Have a personal or library account? Click to login
Safety, Efficacy, and Intermediate‑Term Outcomes of CT‑Guided Cryoablation of T1 Renal Cell Carcinoma: A Retrospective Single‑Center Study Cover

Safety, Efficacy, and Intermediate‑Term Outcomes of CT‑Guided Cryoablation of T1 Renal Cell Carcinoma: A Retrospective Single‑Center Study

Open Access
|Mar 2026

Figures & Tables

Table 1

Patient characteristics.

PATIENT CHARACTERISTICSN%
Age
 Mean ± standard deviation69 ± 10
 Range45–88
Sex
 Male5169.5
 Female1830.5
Comorbidities
 Smoking or history of smoking3355.9
 Arterial hypertension4372.9
 Diabetes type I or II1525.4
 Chronic obstructive pulmonary disease711.9
 Chronic kidney disease (CKD)3254.2
CKD stage
 111.7
 235.1
 32135.6
 4813.6
 500
Anticoagulant3050.8
Solitary kidney1016.9
 Partial nephrectomy2033.9
 Radical nephrectomy813.6
 Horseshoe kidney11.7
 Solitary kidney at birth11.7
Polycystic kidneys11.7
Von Hippel–Lindau11.7
Table 2

Tumor characteristics.

TUMOR CHARACTERISTICSN%
Size (mm)
 Mean ± SD23.7 ± 9.9
 Range7–45
Laterality
 R3751.4
 L3548.6
Histology72
 Clear cell RCC2331.9
 Papillary RCC811.1
 Chromophile RCC11.4
 Chromophobe RCC22.8
 RCC with fibromatous stroma/RCC with leiomyomatous stroma11.4
 No biopsy of insufficient sample3751.4

[i] R: right.

[ii] L: left.

[iii] RCC: renal cell carcinoma.

[iv] SD: standard deviation.

jbsr-110-1-3919-g1.png
Figure 1

a. Non‑contrast axial CT scan before the cryoablation shows the exophytic RCC (thin white arrow) in the left kidney (K) and a big renal cyst (C). b. The cryoablation needle is inserted into the RCC through a posterolateral access route. c. Cryoablation needle in the RCC with a surrounding ice ball (thick white arrow). d. Non‑contrast axial CT scan after the procedure shows the ablated RCC (yellow arrow). e. Sagittal reconstruction CT scan shows the ablated RCC (A). f. Coronal reconstruction CT scan shows the ablated tumor (yellow arrow).

jbsr-110-1-3919-g2.pngjbsr-110-1-3919-g3.pngjbsr-110-1-3919-g4.pngjbsr-110-1-3919-g5.png
Figure 2

a. Contrast‑enhanced T1‑weighted MR‑image shows a hypovascular mass lesion (arrows) in the right anterior lower pole. b. Unenhanced, reconstructed parasagittal CT‑image during percutaneous cryoablation procedure shows exophytic mass lesion (arrows) and four needles within the mass lesion. c. Procedural retroperitoneal hemorrhage occurred and subsequent emergent selective angiography revealed two bleeding points (arrows) at the lower pole of the right kidney. d. Selective angiography after coil‑embolization (arrowheads) shows complete occlusion of the bleeding renal end branches.

jbsr-110-1-3919-g6.png
Figure 3

Axial contrast‑enhanced CTs of the patient with two local tumor recurrences. a. RCC lesion in the left lower pole before ablation (white arrows). b. CT scan 3‑month post‑ablation shows no contrast enhancement in the ablation zone (white arrow). c. CT scan 12 months post‑ablation shows contrast enhancement (yellow arrow) in the ablation zone, and thus a local tumor recurrence. d. CT 3 months after the second cryoablation shows no residual tumor in the ablation zone (white arrow). e–f. On the CT 12 (e) and 18 months (f) post‑ablation the contrast enhancement was very subtle (yellow arrow) and stable. Patient is further followed‑up.

jbsr-110-1-3919-g7.png
Figure 4

Kaplan–Meier estimate of local progression‑free survival is 87.4% (standard error of 4.8%) at 1 year.

jbsr-110-1-3919-g8.png
Figure 5

Kaplan–Meier estimate of the OS rates at 1 year was 95.9% (standard error [SE] of 2.8%) and 91.6% (SE: 5.0%) at 3 years.

DOI: https://doi.org/10.5334/jbsr.3919 | Journal eISSN: 2514-8281
Language: English
Submitted on: Mar 6, 2025
|
Accepted on: Feb 19, 2026
|
Published on: Mar 11, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Laura Frenoy, Pieter‑Jan Buyck, Lawrence Bonne, Ben Van Cleynenbreugel, Maarten Albersen, Geert Maleux, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.